Aetna veteran Karen Lynch has been replaced as CEO of CVS Health, less than four years after getting the top job.

Longtime executive David Joyner, 60, took over on Thursday after CVS repeatedly missed earnings targets, setting off unrest ...

A trifecta of problems, some that started before she took the top job, ended the reign of one of the most powerful women in ...

America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David ...

CVS Health stock sold for $72.08 a share when Karen Lynch became president and CEO in 2021. It closed at $60.35 on Friday.

During her time at the helm of CVS Health, former chief executive Karen Lynch often placed her complicated family history at ...

CVS Health Corp. named David Joyner as its new CEO, ending a tumultuous tenure for current CEO Karen Lynch at the pharmacy ...

CVS Health (CVS) announced a change in its chief executive officer and cautioned that its upcoming earnings are likely to ...

It's a tumultuous time at industry giant CVS Health, and on Friday the company revealed a shakeup at the top that now has ...

Shares are down by nearly half from their 2022 highs, in part due to repeated profit forecast cuts related to rising costs in ...

Shares of the health care conglomerate dropped after the sudden departure of Karen Lynch and a downbeat update on the state ...

CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company ...